Barinthus Biotherapeutics plc (BRNS) Tops Q3 EPS by 4c

Barinthus Biotherapeutics plc (NASDAQ: BRNS) reported Q3 EPS of ($0.36), $0.04 better than the analyst estimate of ($0.40).

For earnings history and earnings-related data on Barinthus Biotherapeutics plc (BRNS) click here.

You May Also Be Interested In

• After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
• Autodesk (ADSK) Tops Q2 EPS by 18c, Beats on Revenue; Offers FY27 EPS Guidance
• YouTube Probed By FTC Over Blocked Social Media Accounts - Bloomberg